July 31, 2015. Chemotherapy resistance in breast cancer manuscript accepted for publication

Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning

Authors:  Stephanie N. Dorman^a, Katherina Baranova^a, Joan H.M. Knoll^b,c,d, Brad L. Urquhart^e, Gabriella Mariani^f, Maria Luisa Carcangiu^f, Peter K. Rogan^a,d,g,h*

^aDepartment of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada, ^bDepartment of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada, ^cMolecular Diagnostics Division, Laboratory Medicine Program, London Health Sciences Centre, ON, Canada, ^dCytognomix Inc., London ON, Canada, ^eDepartment of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada, ^fDepartment of Diagnostic and Laboratory Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, ^gDepartment of Computer Science, University of Western Ontario, London, ON, Canada, ^hDepartment of Oncology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada

will be published in a forthcoming issue of the journal “Molecular Oncology”.